Smiths Medical 21-4034-24 - PORT INFUSION SINGLE LUMEN TITANIUM DETACHED SILICONE CATHETER 9FR INTRODUCER LOW PROFILE

Smiths Medical 21-4034-24 - PORT INFUSION SINGLE LUMEN TITANIUM DETACHED SILICONE CATHETER 9FR INTRODUCER LOW PROFILE

The Smiths Medical 21-4034-24 Port Infusion System is a reliable, low-profile implantable vascular access device designed to support long-term infusion therapy. Engineered with a durable titanium port body and a flexible detached silicone catheter, this single lumen system ensures consistent performance, patient comfort, and clinical efficiency. The 9 French catheter size provides optimal flow rates while maintaining a minimally invasive profile for patient use.

This system is designed for repeated access to the vascular system, making it suitable for chemotherapy, parenteral nutrition, antibiotic therapy, and other long-term intravenous treatments. Its low-profile design supports discreet implantation, enhancing patient quality of life without compromising functionality.

Key Benefits

The titanium construction offers exceptional strength and resistance to corrosion, ensuring long-term durability even with repeated needle access. The detached silicone catheter provides flexibility, reducing the risk of kinking and improving patient comfort during movement.

The single lumen configuration allows for efficient and controlled delivery of medications or fluids, minimizing complexity in clinical settings. The low-profile port design helps reduce visibility under the skin, which is particularly beneficial for patient confidence and comfort.

The 9FR introducer system simplifies placement, enabling healthcare professionals to perform procedures with greater precision and reduced insertion time.

Compatibility and Applications

This port infusion system is compatible with standard non-coring needles and infusion sets commonly used in clinical environments. It is suitable for use in hospitals, outpatient clinics, oncology centers, and long-term care facilities.

Typical applications include chemotherapy administration, long-term intravenous antibiotic therapy, total parenteral nutrition, blood sampling, and other therapies requiring repeated vascular access. The device is designed for central venous placement and integrates seamlessly into established infusion protocols.

Usage Guidelines

The device should be implanted by a qualified healthcare professional under sterile conditions, following established surgical protocols for central venous access devices. Proper placement of the catheter tip is essential to ensure optimal function and reduce complications.

Access to the port should be performed using appropriate non-coring needles to preserve septum integrity. Routine flushing with compatible solutions is recommended to maintain patency and prevent occlusion.

Regular monitoring for signs of infection, occlusion, or device malfunction is critical to ensure patient safety and device longevity.

Certifications and Safety Standards

The Smiths Medical port infusion system is manufactured in compliance with stringent medical device quality standards. It adheres to applicable regulatory requirements for implantable vascular access devices, ensuring safety, sterility, and performance consistency.

Each component is tested for biocompatibility and durability, supporting safe long-term implantation. The device is supplied sterile and is intended for single patient use to maintain infection control standards.

Comparison with Competitors

Compared to alternative port systems, this model offers a balanced combination of durability and patient comfort through its titanium port body and silicone catheter design. Many competing products use plastic or composite materials, which may not provide the same level of structural integrity over time.

The low-profile design distinguishes it from bulkier devices, making it more suitable for patients seeking a discreet option. Additionally, the detached catheter configuration provides greater flexibility during placement compared to pre-attached systems, allowing clinicians more control during implantation.

Typical User Profile and Application Scenarios

This product is ideal for oncologists, interventional radiologists, and vascular surgeons who require a dependable long-term access solution for their patients. It is frequently used in oncology departments for chemotherapy delivery and in chronic care settings for ongoing intravenous therapies.

Patients who benefit from this device include those undergoing long-term treatment regimens, individuals requiring frequent blood draws, and those needing reliable central venous access without repeated peripheral needle insertions.

Best Practices for Use and Maintenance

To ensure optimal performance, the port should be accessed using proper aseptic techniques at all times. Routine flushing protocols should be followed as recommended by clinical guidelines to maintain catheter patency.

Periodic inspection of the access site is important to detect any early signs of infection or complications. Healthcare providers should educate patients on recognizing symptoms such as redness, swelling, or discomfort at the implant site.

Proper needle selection and handling techniques will help extend the life of the septum and maintain consistent device functionality over time.

Regulatory and Safety Information

This device is intended for use by trained healthcare professionals and must be implanted and managed according to established medical protocols. It is supplied sterile and should not be reprocessed or reused.

All procedures involving the device should comply with institutional policies and regulatory guidelines governing implantable medical devices. Any adverse events or device-related complications should be reported in accordance with applicable reporting requirements.

How to Order

To place an order for the Smiths Medical 21-4034-24 Port Infusion System, contact CIA Medical Customer Care at (312) 275-5850. Our team is available to assist with product selection, bulk pricing, and shipping details to ensure timely delivery for your facility.